Prosecution Insights
Last updated: April 19, 2026

Mabwell (Shanghai) Bioscience Co. Ltd.

2 pending office actions

Portfolio Summary

2
Total Pending OAs
0
Final Rejections
2
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18265223 ANTI-HUMAN B7-H3 ANTIBODY AND APPLICATION THEREOF HOWARD, ZACHARY C 1674 Non-Final OA Jun 02, 2023
17996802 SINGLE VARIABLE DOMAIN ANTIBODY TARGETING HUMAN PROGRAMMED DEATH LIGAND 1 (PD-L1) AND DERIVATIVE THEREOF HOPKINS, SAMANTHA LAKE 1641 Non-Final OA Oct 21, 2022

Managing Mabwell (Shanghai) Bioscience Co. Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month